Cite
MLA Citation
P. Pautier et al.. “A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study).” European journal of cancer, vol. 125, 2020, pp. 31–37. http://access.bl.uk/ark:/81055/vdc_100098645135.0x000032